Registrational Study for 150 Mg/m2 Dose

Trial Profile

Registrational Study for 150 Mg/m2 Dose

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Sep 2007

At a glance

  • Drugs Lamivudine; Nevirapine; Zidovudine
  • Indications HIV infections
  • Focus Pharmacokinetics; Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Sep 2007 The expected completion date for this trial is now 1 Dec 2004.
    • 30 Aug 2007 Status change from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top